EQS-News: Marinomed Biotech AG / Key word(s): Half Year ResultsMarinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities 17.08.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed Biotech AG reports record re.
EQS-News: Marinomed Biotech AG / Key word: Miscellaneous
Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories.
EQS-News: Marinomed Biotech AG / Key word(s): MiscellaneousMarinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd. 09.08.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed enters first long-term Solv4U part.